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Abstract
Introduction: Follow-up of patients with oral cancer is being questioned with regard to financial costs and
effectiveness. Therefore, the aim of the present study was to evaluate whether local recurrence and cervical lymph
node metastases were first discovered clinically or by routine computer tomography.
Materials and methods: The records of all 317 patients that were treated for an oral cancer between 1998 and
2008 were systematically reviewed. Criteria for inclusion were tumor histology with a squamous cell carcinoma of
the head and neck, and regular follow-up examinations with a minimum follow-up time of 12 months, including
clinical and radiological (CT) controls. All patients had the first CT after 6 months, followed by yearly CT controls.
Results: Out of 315 patients with an oral squamous cell carcinoma, 294 were evaluated. Those experiencing
neither recurrence of the tumor nor lymph node metastases constituted 62%. Local recurrence was seen in 36
(12%), lymph node metastases in 32 (11%), and both in 16 (6%). Of the 32 patients with lymph node metastases,
25 were recognized first clinically, and 7 were detected by routine CT scans; concerning local recurrence, 32
appeared clinically, and 4 were detected by routine CT scans.
Conclusion: Routine CT for follow-up is still indicated for detecting lymph node metastases as well as local
recurrence.
Introduction
The 5-year disease-specific survival rate for patients with
primary oral cancer ranges from 53% [1] to 74% [2].
Most of the locoregional recurrences and lymph node
metastases in head and neck cancer occur within the
first two years [3,4]. The status of the lymph nodes
appears to be one of the most important prognostic fac-
tors for patients with squamous cell carcinoma (SCC) of
the head and neck, and recurrent disease seems to be
associated with decreased survival [5]. Examination of
the neck is based mainly on palpation.
Follow-up, including CT scans, of patients with oral
cancer is being questioned with regard to financial costs
and effectiveness. Most of the studies dealing with
detection of cervical lymph node metastases are preo-
perative assessments. In surgically treated or radiated
necks, the assessment seems to be more difficult due to
scar tissue. Therefore, the aim of the present study was
to evaluate whether local recurrence and cervical lymph
node metastases were first discovered clinically or by
routine computer tomography.
Materials and methods
The records of all 317 patients treated for oral cancer
between 1998 and 2008 at the Department of Cranio-
maxillofacial and Oral Surgery, University Hospital Zur-
ich, were systematically reviewed. Criteria for inclusion
were tumor histology with an SCC of the head and
neck, and regular follow-up examinations, with a mini-
mum follow-up time of 12 months, including clinical
and radiological (CT) controls. Criteria for exclusion
were inadequate information, tumors in other regions of
the head and neck (e.g., salivary glands, skin), and
patients with previous oral carcinoma. All patients had
the first CT after 6 months, followed by yearly CT con-
trols. Clinical controls were performed once per month
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in the first year; in the second year, every 2 months; in
the third year, every 3 months; in the fourth year, every
6 months; and once per year after the fifth year (Table
1). Due to inadequate information, only 294 patients
were included. Data of recurrence, lymph node metas-
tases, and second head and neck cancer were analyzed.
Results
Out of 294 patients with an oral squamous cell carci-
noma, the male-female ratio was 172:122 with a median
age of 62.25 years; those experiencing no tumor recur-
rence or lymph node metastases constituted 62%. Local
recurrence was seen in 36 (12%), lymph node metastases
in 32 (11%), and both in 16 (6%) (Figure 1).
Out of 32 patients with lymph node metastases, 25
were first recognized clinically, and 7 were detected by
routine CT scans; concerning local recurrence, 32
appeared clinically, and 4 were detected by routine CT
scans (Figure 2).
Local recurrences (Figure 3) appear later than lymph
node metastases (Figure 4). The combination of both
(Figure 5) had the longest time to event. The exact data
is given in Table 2.
Discussion
Palpation alone for assessment of cervical lymph node
metastases seems to be unreliable [6]. For staging, ultra-
sonography, computed tomography, and magnetic reso-
nance imaging (MRI) are generally considered superior
to palpation [7]. Concerning the comparison between
palpation, CT, and low field MRI, Atula et al. were able
to show, in 86 patients without palpable normal necks,
that CT (23 positive) was superior to low field MRI (10
positive) and ultrasonography (12 positive) [6]. Yousem
et al. arrived at similar results by studying central nodal
necrosis and extracapsular spread, experiencing a more
accurate detection by CT in comparison to unenhanced
or enhanced MRI [8]. In one of the largest meta-ana-
lyses, de Bondt et al. showed that ultrasonography-
guided fine needle aspiration cytology had the highest
diagnostic odds ratio (DOR = 260), compared to
Table 1 Follow-up schema
TIME CLINICAL CONTROL RADIOLOGICAL CONTROL
Year 1 monthly control after 6 and 12 months
Year 2 every 2 months control once a year
Year 3 every 3 months control once a year
Year 4 every 6 months control once a year
From year 5 once a year control only in suspicious cases
Figure 1 Clinical and radiological assessment of recurrence and lymph node metastases.
Figure 2 Determination of follow-up results.
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ultrasonography (DOR = 40), CT (DOR = 14), and MRI
(DOR = 7) [9].
Nowadays, FDG-PET seems to play a more and more
intensive role in lymph node metastasis or second
tumor assessment. Recently Yamazaki et al. studied
1076 lymph nodes with preoperative FDG-PET and CT.
FDG-PET detected 100% of metastatic lymph nodes ≥
10 mm and intranodal tumor deposits ≥ 9 mm, and had
fewer false-positives than did CT [10].
Several CT criteria for assessing nodal metastases have
been discussed, like nodal size criteria (greatest diameter
more than 1.5 cm for jugolodigastric and submandibular
nodes, more than 1 cm for all other lymph nodes) nodal
shape (more spherical shape in metastastic nodes),
nodal grouping (three or more, each with a diameter of
8-15 mm), and central necrosis [11]. But in postopera-
tive or radiated necks, the evaluation appears to be
more difficult that in the preoperative status.
Some authors advocate the use of ultrasound due to
good results in lymph node control [12] and lower
costs, while others [8,13] prefer CT scans due to a
higher sensitivity from CT imaging in comparison to
ultrasound. One reason may be the better detection of
deep cervical nodes by CT (Figure 6).
More than two-thirds of locoregional recurrences and
lymph node metastases occur within the first two years
[14,15]. In the present study, local recurrence (Figure 3)
appeared later in comparison to lymph node metastases
(Figure 4).
Concerning detection of local recurrence by CT scans,
data from the literature are not available. In the present
study, local recurrence was detected first by CT scans
in 4 patients (Figure 2); 3 out of these 4 were localized
in the orbit and one in the maxilla (Figure 7). One rea-
son could be that locations like mouth floor or tongue
Figure 4 Frequency and time of lymph node metastases
(months).
Figure 5 Frequency and time of combined lymph node
metastases and local recurrence (months).
Table 2 Data of recurrence and LN metastasis (Missing =
Patients without local recurrence or LN metastasis during
follow-up)
Time of
recurrence
Time of LN
metastases
Time of recurrence and
LN metastases
N Valid 36 32 16
Missing 48 52 68
Median 18,00 9,00 23,50
Std.
Deviation
13,944 5,023 11,525
Minimum 5 7 7
Maximum 51 28 42
Figure 3 Frequency and time of local recurrence (months).
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can be better observed. Therefore, in cases of poorer
visual assessment, like in the reconstructed maxilla, CT
can be advantageous for local control, whereas ultraso-
nography does not have a field of indication. Another
alternative could be 18F-FDG PET/CT, but it is not
available in all hospitals and is more cost intensive.
Abgral et al., in 91 patients without clinical evidence of
recurrence of head and neck SCC that were examined
by 18F-FDG PET/CT, demonstrated proven recurrence
in 30 patients [16].
The present study demonstrates that a reduction in
the follow-up period of 5 years is not acceptable, in par-
ticular with regard to local recurrences. CT is still indi-
cated for follow-up controls besides the clinical
controls, but the alternative of ultrasonography, in parti-
cular for neck evaluation, should be taken into further
consideration.
Conclusion
Routine CT for follow-up is still indicated for detecting
lymph node metastases as well as local recurrence.
Ultrasonography does have a growing importance for
detection of lymph node metastasis but not for local
recurrences. Thorough clinical investigation is of course
the baseline diagnostic.
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